T0	Participants 131 164	superficial basal cell carcinoma.
T1	Participants 305 345	superficial basal cell carcinoma (sBCC).
T2	Participants 354 371	Patients (n = 32)
T3	Participants 707 754	30 patients (13 females), 14 on R1 and 16 on R2
T4	Participants 1325 1330	sBCC.